Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in ...

from 12:30 PM to 1:30 PM PDT In addition to the poster presentations during DDW, Ardelyx is sponsoring a Product Theater titled: “Integrating a Different Mechanism of Action, a different Class ...

today announced that the Company will present a Late-Breaking scientific poster at the upcoming 2025 American Thoracic Society (ATS) International Conference taking place May 16-21, 2025 ...

Poster presentations across all programs ... and new data and analyses are reserved for presentation at the conference. Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company ...

Poster presentations across all programs ... and new data and analyses are reserved for presentation at the conference. Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company ...

April 24, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that ...

International Conference, taking place in San Francisco, California from May 16 - May 21, 2025. These posters and presentations will highlight new translational data demonstrating buloxibutid's ...